A Phase 3 interventional study of Laparoscopic restrictive procedure and Sleeve gastrectomy in Morbid Obesity, sponsored by North Texas Veterans Healthcare System. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2009-12-15.
Sponsored by North Texas Veterans Healthcare System · Phase 3, Interventional, and Treatment
This is a phase 3 prospective randomized trial.
6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.
This study's planned enrollment of 30 is below the median of 78 across 4,878 interventional studies indexed under Obesity.
Browse Obesity studies →North Texas Veterans Healthcare System is the lead sponsor of 31 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Procedure: Laparoscopic restrictive procedure
Procedure: Sleeve gastrectomy
Patients will receive laparoscopic sleeve gastrectomy with or without omentectomy
Sleeve gastrectomy
Weight loss
Time frame: 5 years
Metabolic outcomes
Time frame: 5 years
Diabetes resolution
Time frame: 5 years
This study is completed, as verified in Aug 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
North Texas Veterans Healthcare System